Release Date: 10/05/16 18:15 Summary: Completion of Rights Issue and Equity Conversion of Debt-DIG.AX Price Sensitive: Yes Download Document 98.51KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status